Product Overview

Cifogru 2mg/mL Vial is a potent prescription antibiotic designed to combat a wide spectrum of bacterial infections.

Its active ingredient, Cefotaxime, belongs to the cephalosporin class of antibiotics, known for its broad-spectrum efficacy.

This medication is specifically formulated for injectable administration, ensuring rapid and effective delivery to the site of infection.

It is crucial that Cifogru 2mg/mL Vial is administered by a qualified healthcare professional, as correct dosage and administration technique are vital for patient safety and treatment success.

Benefits of Use

• Broad-Spectrum Efficacy: Targets and eliminates a wide range of Gram-positive and Gram-negative bacteria, making it effective against various types of infections.
• Treatment of Serious Infections: Indicated for severe bacterial infections including respiratory tract infections, urinary tract infections, skin and soft tissue infections, bone and joint infections, intra-abdominal infections, septicemia, and meningitis.
• Rapid Action: Administered by injection, it quickly achieves therapeutic concentrations in the bloodstream to efficiently combat infections.
• Reliable Antimicrobial Action: Provides a powerful and effective solution against resistant bacterial strains, contributing to successful treatment outcomes.

How to Use

1. Cifogru 2mg/mL Vial is for injectable use only and must be administered by a healthcare professional.
2. The powder in the vial must be reconstituted with a suitable sterile diluent (e.g., sterile water for injection, 0.9% sodium chloride) prior to administration.
3. Dosage, frequency, and duration of treatment will be determined by the physician based on the patient's age, weight, severity of infection, and renal function.
4. It can be administered via slow intravenous (IV) injection over 3 to 5 minutes or by intravenous infusion over 20 to 60 minutes.
5. It can also be administered via intramuscular (IM) injection for certain indications, typically into a large muscle mass.

Caution & Warnings

• Hypersensitivity: Not to be administered to patients with a known history of hypersensitivity to Cefotaxime, other cephalosporins, or any component of the formulation. Cross-sensitivity with penicillins may occur.
• Renal and Hepatic Impairment: Dosage adjustments may be required in patients with significant renal or hepatic impairment. Close monitoring is advised.
• Gastrointestinal Disorders: Pseudomembranous colitis, caused by Clostridium difficile, has been reported with nearly all antibacterial agents, including Cefotaxime. This diagnosis should be considered in patients who present with diarrhea following antibiotic administration.
• Pregnancy and Lactation: The drug should be used during pregnancy and lactation only if the potential benefit outweighs the potential risk to the fetus or infant. Consult a physician.
• Development of Resistance: Prolonged use may result in the overgrowth of non-susceptible organisms. Patients should complete the full course of therapy as prescribed, even if symptoms improve.
• Injection Site Reactions: Pain, inflammation, or phlebitis may occur at the injection site. Ensure proper administration technique.

Ingredients

Active ingredient: Cefotaxime (as Cefotaxime Sodium).

Product Details

Form: Sterile powder for injection (vial).

Concentration: 2 mg/mL (after reconstitution).

Manufacturer: Tabuk Pharmaceutical Manufacturing Company.